WEHI scientists discovered a drug that blocks long COVID in mice and may improve acute treatment options beyond current ...

Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...

Although Paxlovid did not demonstrate widespread efficacy, a novel approach to long COVID research has emerged.

Looking beyond jabs, sprays or tablets, scientists are thinking outside the box for delivering antiviral medication to ...

The following is a summary of “Patterns in prescribing and dispensing of influenza antivirals among adults with influenza ...

Bacteria, which are susceptible to infection by bacteriophages, often carry multiple genes encoding anti-phage defense ...

Wesley Sundquist, a biochemist at University of Utah, and Tomas Cihlar, a virologist at Gilead, a biopharmaceutical company, ...

The existing preventive measures through vaccinations face constraints in their fight against infections caused by influenza and herpes simplex virus (HSV) (1 Trusted Source Debulking ...

Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

Researchers assessed whether participation in Ryan White services improves outcomes among patients with hepatitis C virus and HIV coinfection.

The recent analysis by Report Ocean on the “Vietnam Antiviral Coatings Market” Report 2024 to 2032 revolves around various aspects of the market, including characteristics, size and growth, ...